Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: An LGE-CMR study

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 4, 2013, Pages 430-436

  Scott, Paul A ^a,b   Rosengarten, James A ^a,b   Murday, David C ^a,b   Peebles, Charles R ^a   Harden, Stephen P ^a   Curzen, Nick P ^a,b   Morgan, John M ^a,b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

arrhythmia; coronary artery disease; implantable cardioverter defibrillator; magnetic resonance imaging; mortality; sudden cardiac death

Indexed keywords

GADOBENATE DIMEGLUMINE;

AGED; ARRHYTHMOGENESIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LATE GADOLINIUM ENHANCEMENT CARDIAC MAGNETIC RESONANCE IMAGING; LEFT VENTRICULAR SCAR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SUDDEN DEATH;

AGED; ARRHYTHMIAS, CARDIAC; CICATRIX; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875842964     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12035     Document Type: Article

References (23)

1. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA,: Systematic review: Implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007; 147: 251-262.
2. Buxton AE, Ellison KE, Lorvidhaya P, Ziv O,: Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation. J Cardiovasc Pharmacol 2010; 55: 450-455.
3. Scott PA, Sterns LD, Tang AS,: Do patients at high risk of nonsudden cardiac death benefit from prophylactic icd therapy Curr Opin Cardiol 2012; 27: 1-7.
4. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ,: Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-28.
5. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM,: Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002; 106: 2322-2327.
6. Roes SD, Borleffs CJW, van der Geest RJ, Westenberg JJM, Marsan NA, Kaandorp TAM, Reiber JHC, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ,: Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator/clinical perspective. Circul: Cardiovasc Imag 2009; 2: 183-190.
7. Scott PA, Morgan JM, Carroll N, Murday DC, Roberts PR, Peebles CR, Harden SP, Curzen NP,: The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2011; 4: 324-330.
8. National Institute for Health and Clinical Excellence: Guidance on implantable cardioverter defibrillators. National Institute for Health and Clinical Excellence web site. Available from: http://www.Nice.Org.Uk/guidance/ ta95. Accessed August 16, 2012.
9. National Institute for Health and Clinical Excellence. Cardiac resynchronisation for the treatment of heart failure. National Institute for Health and Clinical Excellence web site. Available from: http://www.Nice.Org.Uk/ guidance/ta120. Accessed August 16, 2012.
10. Rosset A, Spadola L, Ratib O,: Osirix: An open-source software for navigating in multidimensional DICOM images. J Digit Imaging 2004; 17: 205-216.
11. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS,: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002; 18: 539-542.
12. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ,; PainFREE Rx II Investigators: Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators. Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591-2596.
13. Schoenfeld DA,: Sample-size formula for the proportional-hazards regression model. Biometrics 1983; 39: 499-503.
14. Bradburn MJ, Clark TG, Love SB, Altman DG,: Survival analysis part iii: Multivariate data analysis-Choosing a model and assessing its adequacy and fit. Br J Cancer 2003; 89: 605-611.
15. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ,: Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011; 57: 821-828.
16. de Haan S, Meijers TA, Knaapen P, Beek AM, van Rossum AC, Allaart CP,: Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: Comparison of previously validated models. Heart 2011; 97: 1951-1956.
17. Boye P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ, Dietz R, Schirdewan A, Schulz-Menger J,: Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. JACC Cardiovasc Imaging 2011; 4: 871-879.
18. Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, Marbán E E, Lima JA, Tomaselli GF, Weiss RG,: Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death / clinical perspective. Circ Cardiovasc Imaging 2012; 5: 178-186.
19. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JGF, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC,: Prediction of mode of death in heart failure. Circulation 2007; 116: 392-398.
20. Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH,: Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation 2009; 120: 835-842.
21. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML,: Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008; 51: 288-296.
22. Bailey JJ, Berson AS, Handelsman H, Hodges M,: Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 2001; 38: 1902-1911.
23. Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ,: Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012; 60: 408-420.